This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bovine Asymmetrical Dimethylarginine (ADMA) ELISA Kit-Competitive
Product Overview
BioVenic Bovine Asymmetrical Dimethylarginine (ADMA) ELISA Kit-Competitive is designed for the quantitative determination of Bovine Asymmetrical Dimethylarginine (ADMA) in serum, plasma, tissue homogenate, cell culture supernatant, cell extract, and other biological fluids using a Competitive ELISA method. For research use only.
Specifications
Target Information
Asymmetric dimethylarginine (ADMA), an endogenous competitive inhibitor of nitric oxide synthase, is associated with impaired endothelial dysfunction such as chronic heart failure, hypertension, diabetes, and pulmonary hypertension. Research has shown that ADMA can inhibit the proliferation of bovine retinal capillary endothelial cells (BRCECs), increase intracellular ROS generation, increase cell permeability and, in BRCECs, decrease the levels of the tight junction protein occludin and increase ICAM-1 expression.
Shipping and Storage
This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.